💊

Prescription Drugs

💊 Drugs • 11,927 recalls

Fludeoxyglucose F 18 Injection, 20mCi/mL to 200 mCi/mL at EOS, 30 mL Multiple-Dose Vial, Rx Only, Manufactured by: Lantheus MI Radiopharmaceuticals, Inc., San Juan, PR --- NDC 11994-015-01

Lantheus MI Radipharmaceuticals

Class I - Dangerous

Failed Impurities/Degradation Specifications; out of specification result for Acetonitrile residual solvent

May 18, 2017 Prescription Drugs View Details →

Bupivacaine HCl 0.25% 400 mL Total Volume in an ON-Q Pump in 0.9% Sodium Chloride Injection in 400 mL, Rx Only, Compounded by PharMEDium Services, LLC, Sugar Land, TX 77478, NDC: 61553-023-09

Pharmedium Services

Class I - Dangerous

Labeling: Incorrect or Missing Lot and/or Exp Date

Feb 15, 2017 Prescription Drugs Nationwide View Details →

Ropivacaine HCl 0.2% 550 mL Total Volume in an AutoFuser Pump in 0.9% Sodium Chloride Injection, Rx Only, Compounded by PharMEDium Services, LLC, Sugar Land, TX 77478, NDC: 61553-100-13

Pharmedium Services

Class I - Dangerous

Labeling: Incorrect or Missing Lot and/or Exp Date

Feb 15, 2017 Prescription Drugs Nationwide View Details →

Blephamide (sulfacetamide sodium and prednisolone acetate ophthalmic ointment, USP) 10%/0.2% sterile, 3.5 g tube, RX only, Manufactured by Allergan, Irvine, California, 92612, U.S.A., NDC: 0023-0313-04.

Allergan Sales

Class I - Dangerous

Failed Impurities/Degradation Specifications: stability testing results did not meet the specification for impurities.

May 1, 2017 Prescription Drugs Nationwide View Details →

Progesterone Injection in Olive Oil With Benzyl Alcohol 10%, 50mg/mL, 10mL Multi-Dose Vial, Rx only, Apothecary by Design, 141 Preble Street, Portland, ME.

Apothecary By Design

Class I - Dangerous

Lack of Processing Controls: The metal container closure adheres to the rubber stopper on some of the units of the batch which can impact the integrity of the container closure.

Jun 5, 2017 Prescription Drugs Nationwide View Details →

Gaviscon (Alumina & Magnesium Trisilicate) Regular Strength Original Flavor Chewable Tablets, 80 mg & 14.2 mg, 100-count bottles, Distributed by: GlaxoSmithKline Consumer Healthcare, L.P., Moon Twp, PA 15108, UPC 3 0088-1175-47 8.

Sanofi-Aventis U.S.

Class I - Dangerous

Superpotent Drug: high out-of-specification result for magnesium.

Jun 12, 2017 Prescription Drugs Nationwide View Details →

BuPROPion HCL Tablets, USP, 75 mg, packaged as UD 100 tablets (10x10), Rx Only, Mfg by: Sandoz Inc., 508 Carnegie Center, Suite 400, Princeton, NJ 08805, NDC: 63739-706-10

Mckesson Packaging Services

Class I - Dangerous

Failed Moisture Limits: Product tested out-of-specification for moisture content.

May 30, 2017 Prescription Drugs Nationwide View Details →

Minivelle (estradiol Transdermal System) 0.1 mg per day, pack of 8 systems per carton, Rx only, Dist. by: Noven Therapeutics, LLC. Miami, Florida 33186. NDC: 68968-6610-8

Noven Pharmaceuticals

Class I - Dangerous

Defective Delivery System: Out of specification for peel force from the release liner specification during stability testing at 18M 25C/60%RH.

Apr 27, 2017 Prescription Drugs Nationwide View Details →

Doxycycline Hyclate USP, active pharmaceutical ingredient, a) 25 g packaged in a 500 cc container (NDC: 58597-8082-4), b) 100 g packaged in 16 oz container (NDC: 58597-8082-6), c) 500 g packaged in a 2500 cc container (NDC: 58597-8082-7) and a 1,000 g packaged in 1 gallon container (NDC: 58597-8082-8). For Prescription Compounding RX Only. Packed under cGMP conditions by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327

American Pharmaceutical Ingredients

Class I - Dangerous

Labeling: Not Elsewhere Classified. Manufacturer and product were discovered to be on FDA Import Alert 66-66 for misbranding of active pharmaceutical ingredient.

Jun 1, 2017 Prescription Drugs Nationwide View Details →